Abizer Gaslightwala - CEO, Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Abizer Gaslightwala - trading volume in the past year for Akari Therapeutics Plc

Holdings reported by Abizer Gaslightwala for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 299K $269K $0.90 Aug 25, 2025 Direct
Series A Warrants (Right to Buy) 134K $150K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 134K $150K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
American Depository Shares representing Ordinary Shares 47.5K $58K $1.22 Jan 10, 2025 Direct
Ordinary Shares, par value $0.0001 per share 71.7M $43K $0.00 Jan 3, 2025 Direct
Stock Option (Right to Buy) 600K Mar 20, 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Abizer Gaslightwala for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.